What this means
This is a trial that is still signing up people, so no results exist yet. It will test whether strength training plus creatine can protect muscle during GLP-1 drug weight loss.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18 and over
- Where
- 1 site
The science
- Registered title
- Creatine Supplementation During GLP-1a Therapy
- Trial ID
- NCT07625202 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Sarcopenia
- What is tested
- Dietary supplementation during a 12 week resistance-training program (creatine), Dietary supplementation during a 12 week resistance-training program (placebo)
- Sponsor
- University of Saskatchewan
- Ages
- 18 Years to no maximum
- Dates
- First posted Jun 4, 2026 · updated Jun 4, 2026
Registry summary
GLP-1 receptor agonists are effective for weight loss, but significant muscle mass is lost as a proportion of this weight loss. This study combines resistance-training and creatine supplementation to try to prevent this loss of muscle mass.
Sites (1)
- University of Saskatchewan, Saskatoon, SK - Saskatchewan, Canada